Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
Frequently asked questions
What sector does FIN.DE TUBIZE ACT.NOUV. (FTD) operate in?
FIN.DE TUBIZE ACT.NOUV. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is FIN.DE TUBIZE ACT.NOUV. (FTD) current stock price?
As of the latest data, FIN.DE TUBIZE ACT.NOUV. stock price is €186.10, with a previous close of €189.90. FIN.DE TUBIZE ACT.NOUV. lost -€3.80 in the last trading session, representing a -2% loss.
What is FIN.DE TUBIZE ACT.NOUV. (FTD) current market capitalization?
FIN.DE TUBIZE ACT.NOUV. market cap is approximately 8.28 billion.
What is FIN.DE TUBIZE ACT.NOUV. (FTD) Earnings Per Share (EPS)?
The trailing EPS is €2.21.
What is FIN.DE TUBIZE ACT.NOUV. (FTD) Price-to-Earnings (P/E) ratio?
FIN.DE TUBIZE ACT.NOUV. current P/E ratio is 84.21.
Does FIN.DE TUBIZE ACT.NOUV. (FTD) pay dividends?
Yes. FIN.DE TUBIZE ACT.NOUV. pays annual dividends with an annualized yield of 0.58% and an estimated annual payout of €1.08 per share.
When is the next ex-dividend date for FIN.DE TUBIZE ACT.NOUV. (FTD)?
The next ex-dividend date is scheduled for May 07, 2027.
When is FIN.DE TUBIZE ACT.NOUV. (FTD) next earnings report?
FIN.DE TUBIZE ACT.NOUV. is expected to release its next earnings report on June 30, 2026.
What is FIN.DE TUBIZE ACT.NOUV. (FTD) beta (volatility) score?
FIN.DE TUBIZE ACT.NOUV. has a beta of 0.392, indicating lower volatility than the overall market.